• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

OC43冠状病毒与细胞膜的病毒-配体相互作用。

Virus-ligand interactions of OC43 coronavirus with cell membranes.

作者信息

Collins A R

机构信息

Department of Microbiology, State Univ. of NY at Buffalo 14214.

出版信息

Adv Exp Med Biol. 1993;342:285-91. doi: 10.1007/978-1-4615-2996-5_44.

DOI:10.1007/978-1-4615-2996-5_44
PMID:8209744
Abstract

The binding of human coronavirus OC43 to human rhabdomyosarcoma cells which are highly susceptible to infection was studied by a solid phase virus binding assay and a receptor blockade assay. It was observed that whole virions and S(spike) bound to a 90 kD glycoprotein of RD cells even after treatment of the substrate with neuraminidase or 0.1 M NaOH. A second receptor of 45 kD also bound virus and was identified as HLA class I antigen. Antibody to both receptors reduced the virus yield in a receptor blockade assay. Sera from four patients with multiple sclerosis contained receptor blocking activity which correlated with antibodies to HLA. No receptor blocking antibodies to the 90 kD RD cell protein were found in human sera.

摘要

通过固相病毒结合试验和受体阻断试验研究了人冠状病毒OC43与对感染高度敏感的人横纹肌肉瘤细胞的结合。观察到,即使在用神经氨酸酶或0.1 M NaOH处理底物后,完整病毒粒子和S(刺突)仍与RD细胞的一种90 kD糖蛋白结合。一种45 kD的第二受体也能结合病毒,并且被鉴定为HLA I类抗原。在受体阻断试验中,针对这两种受体的抗体均降低了病毒产量。四名多发性硬化症患者的血清含有与抗HLA抗体相关的受体阻断活性。在人血清中未发现针对90 kD RD细胞蛋白的受体阻断抗体。

相似文献

1
Virus-ligand interactions of OC43 coronavirus with cell membranes.OC43冠状病毒与细胞膜的病毒-配体相互作用。
Adv Exp Med Biol. 1993;342:285-91. doi: 10.1007/978-1-4615-2996-5_44.
2
HLA class I antigen serves as a receptor for human coronavirus OC43.
Immunol Invest. 1993 Mar;22(2):95-103. doi: 10.3109/08820139309063393.
3
Human coronavirus OC43 interacts with major histocompatibility complex class I molecules at the cell surface to establish infection.
Immunol Invest. 1994 Aug;23(4-5):313-21. doi: 10.3109/08820139409066826.
4
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection.鉴定主要组织相容性复合体I类C分子作为一种促进冠状病毒HKU1刺突介导感染的附着因子。
J Virol. 2009 Jan;83(2):1026-35. doi: 10.1128/JVI.01387-08. Epub 2008 Nov 5.
5
Coronavirus receptor specificity.冠状病毒受体特异性。
Adv Exp Med Biol. 1993;342:261-6. doi: 10.1007/978-1-4615-2996-5_40.
6
Recognition of N-acetyl-9-O-acetylneuraminic acid by bovine coronavirus and hemagglutinating encephalomyelitis virus.牛冠状病毒和血凝性脑脊髓炎病毒对N-乙酰-9-O-乙酰神经氨酸的识别。
Adv Exp Med Biol. 1993;342:299-304. doi: 10.1007/978-1-4615-2996-5_46.
7
Mouse hepatitis virus infection utilizes more than one receptor and requires an additional cellular factor.小鼠肝炎病毒感染利用多种受体,并且需要一种额外的细胞因子。
Adv Exp Med Biol. 1993;342:273-7. doi: 10.1007/978-1-4615-2996-5_42.
8
Identification of 120 kD and 30 kD receptors for human coronavirus OC43 in cell membrane preparations from newborn mouse brain.在新生小鼠脑海绵体细胞膜制剂中鉴定人冠状病毒OC43的120 kD和30 kD受体
Adv Exp Med Biol. 1995;380:387-90. doi: 10.1007/978-1-4615-1899-0_63.
9
The N-terminal domain of the murine coronavirus spike glycoprotein determines the CEACAM1 receptor specificity of the virus strain.鼠冠状病毒刺突糖蛋白的N端结构域决定了该病毒株的癌胚抗原相关细胞黏附分子1(CEACAM1)受体特异性。
J Virol. 2003 Jan;77(2):841-50. doi: 10.1128/jvi.77.2.841-850.2003.
10
Identification of the Receptor-Binding Domain of the Spike Glycoprotein of Human Betacoronavirus HKU1.人乙型冠状病毒HKU1刺突糖蛋白受体结合域的鉴定
J Virol. 2015 Sep;89(17):8816-27. doi: 10.1128/JVI.03737-14. Epub 2015 Jun 17.

引用本文的文献

1
Establishment of a screening platform based on human coronavirus OC43 for the identification of microbial natural products with antiviral activity.建立基于人冠状病毒 OC43 的筛选平台,用于鉴定具有抗病毒活性的微生物天然产物。
Microbiol Spectr. 2024 Jan 11;12(1):e0167923. doi: 10.1128/spectrum.01679-23. Epub 2023 Nov 27.
2
Identification of vaccine targets & design of vaccine against SARS-CoV-2 coronavirus using computational and deep learning-based approaches.使用基于计算和深度学习的方法鉴定 SARS-CoV-2 冠状病毒的疫苗靶点和设计疫苗。
PeerJ. 2022 May 19;10:e13380. doi: 10.7717/peerj.13380. eCollection 2022.
3
Improving human coronavirus OC43 (HCoV-OC43) research comparability in studies using HCoV-OC43 as a surrogate for SARS-CoV-2.
提高以人冠状病毒 OC43(HCoV-OC43)作为 SARS-CoV-2 替代物的研究中 HCoV-OC43 研究的可比性。
J Virol Methods. 2022 Jan;299:114317. doi: 10.1016/j.jviromet.2021.114317. Epub 2021 Oct 9.